HLB Panagene is a leading biotechnology company specializing in innovative molecular diagnostic solutions based on proprietary Peptide Nucleic Acid (PNA) technology. The company develops and manufactures assays for oncology, infectious diseases, and precision medicine applications, while also offering a comprehensive portfolio of PNA oligonucleotides for research and diagnostic use. Their advanced PNA platform enables highly sensitive and specific detection of genetic mutations and biomarkers.
HLB Panagene je korejska biotehnološka tvrtka specijalizirana za molekularnu dijagnostiku i PNA (Peptide Nucleic Acid) tehnologiju. U portfelju imaju rješenja za onkologiju, infektivne bolesti, HPV, STD, liquid biopsy aplikacije te proizvode i usluge povezane s PNA oligonukleotidima. Njihova tehnologija koristi se za visokosenzitivnu detekciju mutacija i razvoj precizne dijagnostike.